NitinRohatgiMDMBA

Oncology • Sacramento, CA

Breast Cancer, Genitourinary Oncology

Medical Director, Breast Cancer Program, Sutter Medical Center Sacramento

Join to view full profile

Dr. Rohatgi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rohatgi's full profile

Already have an account?

Office
2800 L St, #300
Sacramento, CA 95816
Phone+1 916-453-3300

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2002
UMass Chan Medical SchoolResidency, Internal Medicine, 1993 - 1996
All India Institute of Medical SciencesClass of 1990

Certifications & Licensure

CA State Medical License 2002 - 2026
OH State Medical License 1998 - 2004
FL State Medical License 1996 - 2002
National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol Start of enrollment: 2014 Mar 01
Unknown status
Join now to see all

Publications & Presentations

PubMed

2 citations
Sunitinib in Patients With Breast Cancer WithorAmplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
JCO Precision Oncology. 2024-02-01
2 citations
Nivolumab Plus Ipilimumab in Patients With Solid Tumors WithMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Nitin Rohatgi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam
JCO Precision Oncology. 2023-09-01
5 citations
Olaparib in Patients With Metastatic Prostate Cancer With/Mutation: Results From the TAPUR Study.
Eddy S Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat
JCO Precision Oncology. 2023-02-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Hindi, Urdu